Next Generation Sequencing in NSCLC – it works, it makes sense….. its time !
This webinar, will discuss the benefits of next generation sequencing (NGS) for simultaneous testing of multiple biomarkers in non-small cell lung cancer.
sponsored by Thermo Fisher Scientific
This webinar, led by Luca Quagliata and Stephen Finn, will discuss the benefits of next generation sequencing (NGS) for simultaneous testing of multiple biomarkers in non-small cell lung cancer. It will highlight the importance of upfront multiplex testing for timely patient stratification, discuss optimization and standardization of the NGS workflow for routine companion diagnostics, and present results from the European Thoracic Oncology Platform Lungscape Project comparing FISH, IHC, PCR and NGS techniques for ALK translocation/fusion detection.